Moderna Starts COVID Vaccine Study For Children Under 12
The study, called kidCOVE, is expected to enroll 6,750 healthy children in the U.S. and Canada.
Watch CBS News
The study, called kidCOVE, is expected to enroll 6,750 healthy children in the U.S. and Canada.
Moderna said early studies show its COVID vaccine is effective against variants of the virus, but it is evaluating booster doses of the vaccine "out of an abundance of caution."
Moderna is anticipating it will have delivered 100 million doses to the U.S. government by the end of March
UMass Medical School is actively recruiting individuals aged 12 to 17 for a clinical trial.
Moderna says it has supplied the federal government with 30.4 million doses of its COVID-19 vaccine so far.
Dr. Anthony Fauci told CBS This Morning Monday that the South African strain is clearly "different and more ominous than the one in the U.K."
Fewer than 10 people, who all received the vaccine at the same community site, needed medical attention over a 24-hour period, officials said.
Moderna's chief medical officer said they will have to test people to see if adding a boost of a third dose might extend protection.
Moderna says the technology it used to develop a COVID-19 vaccine will now be used to develop three new vaccines, including shots for the seasonal flu and HIV.
Two top members of the Food and Drug Administration are dismissing reports about stretching out the vaccine supply.
The FDA will meet this week to consider giving half doses of Moderna's COVID-19 vaccine to some Americans.
Moderna is making its coronavirus vaccine available to its employees.
Cardinal Sean O'Malley has received his first shot of Moderna's coronavirus vaccine.
Frontline workers and residents at the Brockton VA were some of the first to receive it Monday morning.
More relief is on the way as the first doses of Moderna's coronavirus vaccine are set to be distributed Monday.
The FDA gave Moderna emergency use authorization of its COVID-19 vaccine Friday and shipments will begin this weekend.
A U.S. government advisory panel has endorsed a second COVID-19 vaccine.
The Moderna vaccine is very similar to Pfizer's and BioNTech's vaccine.
Moderna's COVID-19 vaccine received a positive review from federal regulators Tuesday.
That will bring the government's total order of 200 million vaccine doses from Moderna.
A Moderna COVID-19 vaccine volunteer is sharing their experience after getting two shots of the experimental drug.
Moderna expects to have 20 million doses of their coronavirus vaccine available in the US by the end of 2020.
Despite experiencing mild side effects, participants from Moderna's COVID vaccine trial are urging the public to take the vaccine.
A CDC committee meets Tuesday to vote on who should be the very first to get vaccinated.
